In This Section

Board of Directors

Nina Bhardwaj, MD, PhD

Nina Bhardwaj, MD, PhD

(2021-2024)

Ward Coleman Chair in Cancer Research
Director of Immunotherapy
Medical Director, Vaccine and Cell Therapy Laboratory
Codirector, Cancer Immunology Program
The Tisch Cancer Institute
Icahn School of Medicine at Mt. Sinai
New York, New York

John D. Carpten, PhD, FAACR

John D. Carpten, PhD, FAACR

(2021-2025)

Professor and Chair, Department of Translational Genomics
Royce and Mary Trotter Chair in Cancer Research
Professor, Department of Urology
Co-director, Institute for Translational Genomics
Director, USC Molecular Genomics Core
Co-leader, NCCC Translational and Clinical Sciences Program
PI-CaRE2 Health Equity Center at USC
Keck School of Medicine
University of Southern California

Christina Curtis, PhD, MSc

Christina Curtis, PhD, MSc

(2022-2025)

Associate Professor and Endowed Scholar, Departments of Medicine and Genetics
Stanford University
Director of Breast Cancer Translational Research and Co-director of the Molecular Tumor Board
Stanford Cancer Institute
Stanford, California

Luis A. Diaz Jr., MD, FAACR

Luis A. Diaz Jr., MD, FAACR

(2021-2024)

Grayer Family Chair
Head, Division of Solid Tumor Oncology
Memorial Sloan Kettering Cancer Center
New York, New York

Silvia Chiara Formenti, MD

Silvia Chiara Formenti, MD

(2020-2023)

Sandra and Edward Meyer Professor of Cancer Research
Professor and Chairman, Department of Radiation Oncology
Weill Cornell Medicine
Associate Director, Sandra and Edward Meyer Cancer Center
Radiation Oncologist-in-Chief
New York Presbyterian Hospital
New York, New York

Elaine Fuchs, PhD, FAACR

Elaine Fuchs, PhD, FAACR

(2020-2023)

Rebecca C. Lancefield Professor and Investigator
Howard Hughes Medical Institute
The Rockefeller University
New York, New York

Susan M. Galbraith, MBBChir, PhD, MRCP, FRCR, FMedSci

Susan M. Galbraith, MBBChir, PhD, MRCP, FRCR, FMedSci

(2021-2024)

Executive Vice-President
Oncology R&D
AstraZeneca
Cambridge, England

Roy S. Herbst, MD, PhD

Roy S. Herbst, MD, PhD

(2020-2023)

Ensign Professor of Medicine
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Comprehensive Cancer Center
Yale School of Medicine
New Haven, Connecticut

Thomas J. Lynch Jr., MD

Thomas J. Lynch Jr., MD

(2021-2024)

President and Director
Raisbeck Endowed Chair
Fred Hutchinson Cancer Research Center
Seattle, Washington

Ira Mellman, PhD, FAACR

Ira Mellman, PhD, FAACR

(2020-2023)

Vice President, Cancer Immunology
Genentech Inc.
South San Francisco, California

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO

(2021-2024)

Chief, Section of Breast Surgery
New York-Presbyterian/Weill Cornell Medical Center
Leader, Multidisciplinary Breast Oncology Programs
New York-Presbyterian David H. Koch Center
Weill Cornell Medicine

William Pao, MD, PhD

William Pao, MD, PhD

(2022-2025)

Chief Development Officer and Executive Vice President
Pfizer

Kimberly Stegmaier, MD

Kimberly Stegmaier, MD

(2022-2025)

Professor of Pediatrics at Harvard Medical School
Ted Williams Investigator, Dana-Farber Cancer Institute
Boston, Massachusetts

Suzanne L. Topalian, MD, FAACR

Suzanne L. Topalian, MD, FAACR

(2020-2023)

Professor of Surgery and Oncology and Associate Director
Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy
Director, Melanoma Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Robert H. Vonderheide, MD, DPhil

Robert H. Vonderheide, MD, DPhil

(2022-2025)

Director, Abramson Cancer Center
Vice Dean and Vice President of Cancer Programs
Perelman School of Medicine and the University of Pennsylvania Health System
Philadelphia, Pennsylvania

View the list of past board members.